Registered Kenya · PPB

HEALIVE PEDIATRIC

HEPATITIS A

H2024/CTD11681/24957 ANTIGEN CONTENT: 250 U / 0.5 ML NEW/INNOVATOR

What it does

Hepatitis is an inflammation of the liver that can be caused by viral infections, alcohol use, or other factors. It can affect liver function and health.

Commonly used for: hepatitis (liver inflammation), viral hepatitis, alcoholic hepatitis

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H2024/CTD11681/24957
Registration date
-
Expiry date
2029 May 06
Status
Registered
Active ingredient
HEPATITIS A
Dosage form
ANTIGEN CONTENT: 250 U / 0.5 ML
Strength
-
Pack size
0.5 ML SUSPENSION IN A PRE-FILLED SYRINGE WITH PLUNGER-STOPPER, STAKED NEEDLE AND NEEDLE SHIELD. PACK SIZE OF 1 SYRINGE. 0.5 ML SUSPENSION IN A VIAL WITH STOPPER AND CAP (ALUMINUM - PLASTICS). PACK SIZE OF 1 VIAL.
Therapeutic class
NEW/INNOVATOR
Manufacturer / MAH
Sai Pharmaceuticals
Applicant / LTR
SINOVAC BIOTECH CO. LTD
Country of origin
FOREIGN
Manufacturer location
Whitefield Edge, Junction of James Gichuru Road and Olengurone Road Lavington Nairobi KE, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 19:20:24 · updated 2026-09-18 02:18:10

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Hepatitis is an inflammation of the liver that can be caused by viral infections, alcohol use, or other factors. It can affect liver function and health.

What it treats

  • hepatitis (liver inflammation)
  • viral hepatitis
  • alcoholic hepatitis

How it works

Hepatitis can occur when the liver is damaged by viruses or toxins, leading to inflammation and impaired liver function.

Who it's for

Anyone can develop hepatitis, but certain groups, like those who consume alcohol excessively or are exposed to infected blood, are at higher risk.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: hepatitis

Hepatitis refers to an inflammatory condition of the liver, which can be caused by viral infections (such as hepatitis A, B, C, D, and E), alcohol consumption, certain medications, and autoimmune diseases. The condition can be acute or chronic, leading to liver damage, cirrhosis, or liver cancer over time. The management of hepatitis depends on its etiology, severity, and the overall health of the patient.

Indications

  • Acute viral hepatitis
  • Chronic hepatitis B
  • Chronic hepatitis C
  • Autoimmune hepatitis
  • Alcoholic hepatitis
  • Non-alcoholic fatty liver disease

Dosage

Children: Paediatric dosing also varies significantly based on the specific condition and medication. As with adult dosing, it is important to refer to the BNF for Children for specific recommendations.

Adults: Dosing for adult patients varies widely depending on the specific antiviral agent used and the type of hepatitis. It is essential to refer to specific guidelines or the BNF for precise dosing.

Mechanism of action

In viral hepatitis, the viruses typically enter liver cells and replicate, leading to cellular injury and inflammation. The immune response to the infection contributes to liver damage. Antiviral therapies aim to inhibit viral replication, either by directly targeting viral enzymes or by modulating the host immune response.

Pharmacodynamics

The pharmacodynamics of antiviral agents used in hepatitis treatment involve the inhibition of viral replication, reduction of viral load, and improvement of liver function. This can lead to a decrease in serum liver enzymes (ALT and AST) and an improvement in clinical symptoms. In chronic hepatitis B and C, sustained virologic response is the goal, indicating effective viral suppression.

Pharmacokinetics

The pharmacokinetics of antiviral medications used for hepatitis can vary significantly depending on the specific drug. Generally, these agents are absorbed from the gastrointestinal tract, metabolized in the liver, and excreted through urine or feces. The half-lives of these drugs can vary, influencing dosing schedules.

Pregnancy

Consult medical guidelines as hepatitis can pose risks during pregnancy; specific management depends on the type of hepatitis.

Breast-feeding

Consult healthcare providers, as the safety of certain hepatitis medications during breastfeeding varies.

Storage

Store in a cool, dry place away from direct sunlight; specific storage conditions may vary based on the medication used.

PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.

Tanzania 17 products
View all 17 in Tanzania →
Zimbabwe 12 products
View all 12 in Zimbabwe →
Ghana 8 products
View all 8 in Ghana →
Rwanda 3 products
South Africa 3 products
Malawi 2 products
Botswana 1 product
Zambia 1 product